Age-dependent α-synuclein aggregation in the Microcebus murinus lemur primate

Scientific Reports

Volumn 2, Issue , 2012, Pages

  Canron, Marie Hélène ^a,b   Perret, Martine ^c   Vital, Anne ^a,b   Bézard, Erwan ^a,b   Dehay, Benjamin ^a,b  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b INSTITUT DES MALADIES NEURODÉGÉNÉRATIVES   (France)

^c MNHN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN;

AGING; ALZHEIMER DISEASE; ANIMAL; ARTICLE; BRAIN; BRAIN MAPPING; CHEIROGALEIDAE; CHEMISTRY; DISEASE MODEL; FEMALE; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; PARKINSON DISEASE; PATHOLOGY; PHOSPHORYLATION; PROTEIN FOLDING;

AGING; ALPHA-SYNUCLEIN; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; BRAIN; BRAIN MAPPING; CHEIROGALEIDAE; DISEASE MODELS, ANIMAL; FEMALE; IMMUNOHISTOCHEMISTRY; MALE; PARKINSON DISEASE; PHOSPHORYLATION; PROTEIN FOLDING;

EID: 84870820743     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep00910     Document Type: Article

References (16)

1. Moore, D. J. & Dawson, T. M. Value of genetic models in understanding the cause and mechanisms of Parkinson's disease. Curr Neurol Neurosci Rep 8, 288-296 (2008).
2. Jenner, P. Functional models of Parkinson's disease: a valuable tool in the development of novel therapies. Ann Neurol 64 Suppl 2, S16-29 (2008).
3. Meredith, G. E., Sonsalla, P. K. & Chesselet, M. F. Animal models of Parkinson's disease progression. Acta Neuropathol 115, 385-398 (2008).
4. Dehay, B. & Bezard, E. New animal models of Parkinson's disease. Mov Disord 26, 1198-1205 (2011).
5. Bezard, E., Yue, Z., Kirik, D. & Spillantini, M. G. Animal models of Parkinson's disease: Limits and relevance to neuroprotection studies. Mov Disord (2012).
6. Austad, S. N. & Fischer, K. E. The development of small primate models for aging research. ILAR J 52, 78-88 (2011).
7. Languille, S. et al. The grey mouse lemur: a non-human primate model for ageing studies. Ageing Res Rev 11, 150-162 (2012).
8. Bons, N., Rieger, F., Prudhomme, D., Fisher, A. & Krause, K. H. Microcebus murinus: a useful primate model for human cerebral aging and Alzheimer's disease? Genes Brain Behav 5, 120-130 (2006). (Pubitemid 43344964)
9. Bons, N., Mestre, N. & Petter, A. Senile plaques and neurofibrillary changes in the brain of an aged lemurian primate, Microcebus murinus. Neurobiol Aging 13, 99-105 (1992).
10. Bons, N. et al. Identification of amyloid beta protein in the brain of the small, short-lived lemurian primate Microcebus murinus. Neurobiol Aging 15, 215-220 (1994).
11. Kraska, A. et al. Age-associated cerebral atrophy in mouse lemur primates. Neurobiol Aging 32, 894-906 (2011).
12. Picq, J. L. Aging affects executive functions andmemory in mouse lemur primates. Exp Gerontol 42, 223-232 (2007).
13. Dhenain, M. et al. MRI description of cerebral atrophy in mouse lemur primates. Neurobiol Aging 21, 81-88 (2000). (Pubitemid 30224789)
14. Dhenain, M. et al. Cerebral T2-weighted signal decrease during aging in the mouse lemur primate reflects iron accumulation. Neurobiol Aging 19, 65-69 (1998). (Pubitemid 28167797)
15. Oueslati, A., Fournier, M. & Lashuel, H. A. Role of post-translational modifications in modulating the structure, function and toxicity of alphasynuclein: implications for Parkinson's disease pathogenesis and therapies. Prog Brain Res 183, 115-145 (2010).
16. Anderson, J. P. et al. Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease. J Biol Chem 281, 29739-29752 (2006). (Pubitemid 44536983)